Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male Ldlr -/- Mice.

García-Jaramillo M, Lytle KA, Spooner MH, Jump DB.

Metabolites. 2019 Oct 28;9(11). pii: E252. doi: 10.3390/metabo9110252.


Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity.

Lytle KA, Bush NC, Triay JM, Kellogg TA, Kendrick ML, Swain JM, Gathaiya NW, Hames KC, Jensen MD.

J Clin Endocrinol Metab. 2019 Dec 1;104(12):6171-6181. doi: 10.1210/jc.2019-00875.


The Soluble Fiber α-Cyclodextrin Does Not Increase the Fecal Losses of Dietary Fat in Adults-A Double-Blind, Randomized, Placebo-Controlled, Crossover Trial.

Lytle KA, Harteneck DA, Noble AM, Jensen MD.

J Nutr. 2018 Sep 1;148(9):1421-1425. doi: 10.1093/jn/nxy135.


Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Jump DB, Lytle KA, Depner CM, Tripathy S.

Pharmacol Ther. 2018 Jan;181:108-125. doi: 10.1016/j.pharmthera.2017.07.007. Epub 2017 Jul 16. Review.


Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.

Lytle KA, Wong CP, Jump DB.

PLoS One. 2017 Apr 19;12(4):e0173376. doi: 10.1371/journal.pone.0173376. eCollection 2017.


Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?

Lytle KA, Jump DB.

PLoS One. 2016 Jan 13;11(1):e0146942. doi: 10.1371/journal.pone.0146942. eCollection 2016.


Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.

Jump DB, Depner CM, Tripathy S, Lytle KA.

Adv Nutr. 2015 Nov 13;6(6):694-702. doi: 10.3945/an.115.009423. Print 2015 Nov. Review.


Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.

Lytle KA, Depner CM, Wong CP, Jump DB.

J Lipid Res. 2015 Oct;56(10):1936-46. doi: 10.1194/jlr.M061275. Epub 2015 Aug 27.


Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.

Jump DB, Depner CM, Tripathy S, Lytle KA.

Proc Nutr Soc. 2016 Feb;75(1):1-9. Epub 2015 Aug 18.


Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.

Tripathy S, Lytle KA, Stevens RD, Bain JR, Newgard CB, Greenberg AS, Huang LS, Jump DB.

J Lipid Res. 2014 Jul;55(7):1448-64. doi: 10.1194/jlr.M050062. Epub 2014 May 9.

Supplemental Content

Loading ...
Support Center